| |
|
|
| |
|
| |
Fovea Pharmaceuticals is a biopharmaceutical company dedicated to the discovery and development of innovation in products for ocular diseases (retinal degeneration, macular edema, glaucoma, and inflammation).
- Back of the eye diseases
- Age related macular degeneration
- Retinal degeneration
- Dry AMD
- Wet AMD
- Retinitis pigmentosa
- Glaucoma
- Diabetic retinopathy
- Stargard's disease
- Retinal vascular diseases
- Diabetic retinopathy
- Ganglion cells degenaration
|
| |
|
| |
| Highlight |
|
• January 7, 2008
Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa
read more
• November 27, 2007
FOVEA Pharmaceuticals Enter into a Research Collaboration in Ophthalmology with GENZYME Corporation
FOVEA Pharmaceuticals SA. announced that they have entered into a Collaborative Research Agreement with GENZYME Corporation. The alliance is anchored around Fovea s proprietary high content technology platform that allows the identification of new targets ...
read more
|
| Focus |
 |
• Fovea's Technology Platform
From identification of putative targets and leads, to translation into clinical trials, Fovea Pharmaceuticals technology platform:
Unique High Content Screening |
| Agenda |
|
• February 11-13, 2008
BIO CEO & Investor Conference
Waldorf Astoria - NEW YORK
Corporate Presentation: February 12, 2008, 3:30 pm
• March 17-20, 2008
COWEN’S 28th Annual Health Care Conference
Boston Marriott Copley Place – BOSTON
• May 5-7, 2008
EUROBIOTECH Forum
Hotel Arts - BARCELONA
Corporate Presentation: May 6, 2008
• May 19-20, 2008
RODMAN & RENSHAW 5th Annual Global Healthcare Conference
Le Meridien Beach Plaza Hotel Monte Carlo – MONACO
|
|
|
